[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
October 2015

Associating Liver Partition and Portal Vein Ligation for Staged HepatectomyA Better Approach to Treat Patients With Extensive Liver Disease

Author Affiliations
  • 1General Surgery Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
JAMA Surg. 2015;150(10):929-930. doi:10.1001/jamasurg.2015.1643

Liver resection is the treatment of choice and a hope for cure for patients with malignant liver tumors. Resection is many times limited by the amount of future liver remnant, with liver failure being the most severe complication after major resections. To minimize this risk and expand resectability, portal vein occlusion of the tumor-bearing lobe is used to redistribute portal flow and induce hypertrophy of contralateral healthy parenchyma. Right portal vein embolization (PVE) is best used before surgery when the future liver remnant is tumor free, while portal vein ligation (PVL) is usually applied as part of 2-stage procedures for patients with bilobar disease who initially require tumor removal in the liver remnant. Around 20% to 40% hypertrophy can be achieved in 8 to 12 weeks with these strategies. However, up to 40% of patients never arrive to tumor resection either because of disease progression or insufficient hypertrophy during these long interval periods.

First Page Preview View Large
First page PDF preview
First page PDF preview
×